Moreover, Del-1 on circulating extracellular vesicles was remarkably elevated in the plasma of two separate cohorts of breast cancer patients, and levels returned to normal after curative surgery, which suggested that Del-1 could be a novel diagnostic marker for early breast cancer [1]. Here, EDIL3 is linked to breast carcinoma.